QIAGEN Aktie
31,91
EUR
-0,06
EUR
-0,19
%
36,28
USD
-0,20
USD
-0,55
%
QIAGEN jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
QIAGEN Aktie Analyse
| 07.05.14 | QIAGEN Hold | Warburg Research | |
| 06.05.14 | QIAGEN Hold | Warburg Research | |
| 04.02.14 | QIAGEN halten | Warburg Research | |
| 03.02.14 | QIAGEN halten | UBS AG | |
| 16.01.14 | QIAGEN halten | Independent Research GmbH | |
| 18.12.13 | QIAGEN halten | Independent Research GmbH | |
| 19.11.13 | QIAGEN halten | Jefferies & Company Inc. | |
| 31.10.13 | QIAGEN halten | Independent Research GmbH | |
|
Werbung
|
|||
| 30.10.13 | QIAGEN halten | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.10.13 | QIAGEN halten | UBS AG | |
| 17.09.13 | QIAGEN halten | UBS AG | |
| 09.08.13 | QIAGEN halten | Independent Research GmbH | |
| 31.07.13 | QIAGEN halten | Jefferies & Company Inc. | |
| 10.06.13 | QIAGEN halten | Independent Research GmbH | |
| 07.06.13 | QIAGEN halten | UBS AG | |
| 02.05.13 | QIAGEN halten | Independent Research GmbH | |
| 01.05.13 | QIAGEN halten | Jefferies & Company Inc. | |
| 30.04.13 | QIAGEN halten | UBS AG | |
| 31.01.13 | QIAGEN halten | Independent Research GmbH | |
| 30.01.13 | QIAGEN halten | UBS AG | |
| 06.11.12 | QIAGEN halten | Independent Research GmbH | |
| 05.11.12 | QIAGEN neutral | UBS AG | |
| 05.09.12 | QIAGEN neutral | UBS AG | |
| 03.09.12 | QIAGEN neutral | Goldman Sachs Group Inc. | |
| 30.07.12 | QIAGEN neutral | HSBC | |
| 27.07.12 | QIAGEN neutral | Exane-BNP Paribas SA | |
| 27.07.12 | QIAGEN halten | Independent Research GmbH | |
| 25.07.12 | QIAGEN neutral | UBS AG | |
| 23.07.12 | QIAGEN neutral | Exane-BNP Paribas SA | |
| 11.07.12 | QIAGEN halten | Independent Research GmbH | |
| 03.07.12 | QIAGEN neutral | Goldman Sachs Group Inc. | |
| 15.06.12 | QIAGEN hold | Jefferies & Company Inc. | |
| 12.06.12 | QIAGEN neutral | UBS AG | |
| 03.05.12 | QIAGEN neutral | HSBC | |
| 02.05.12 | QIAGEN sector perform | RBC Capital Markets | |
| 27.04.12 | QIAGEN halten | Der Aktionärsbrief | |
| 27.04.12 | QIAGEN sector perform | RBC Capital Markets | |
| 26.04.12 | QIAGEN neutral | Exane-BNP Paribas SA | |
| 26.04.12 | QIAGEN neutral | UBS AG | |
| 03.02.12 | QIAGEN neutral | UBS AG | |
| 03.02.12 | QIAGEN sector perform | RBC Capital Markets | |
| 02.02.12 | QIAGEN halten | Independent Research GmbH | |
| 02.02.12 | QIAGEN neutral | Exane-BNP Paribas SA | |
| 02.02.12 | QIAGEN sector perform | RBC Capital Markets | |
| 30.01.12 | QIAGEN sector perform | RBC Capital Markets | |
| 01.12.11 | QIAGEN neutral | Exane-BNP Paribas SA | |
| 01.12.11 | QIAGEN neutral | HSBC | |
| 30.11.11 | QIAGEN neutral | UBS AG | |
| 29.11.11 | QIAGEN halten | Independent Research GmbH | |
| 18.11.11 | QIAGEN sector perform | RBC Capital Markets | |
Werbung
Werbung